Vaccine outlooks. After negative publicity and a series of setbacks over HIV/AIDS and influenza, the prospects for research on new vaccines are improving
- PMID: 20877293
- PMCID: PMC2948189
- DOI: 10.1038/embor.2010.136
Vaccine outlooks. After negative publicity and a series of setbacks over HIV/AIDS and influenza, the prospects for research on new vaccines are improving
Abstract
Vaccine development against HIV and other viruses has suffered a series of setbacks during the past decade. Our improved understanding of human-pathogen interactions and new technologies may now give vaccine developers an edge.
Similar articles
-
Whether and when an AIDS vaccine?Nat Med. 1995 Nov;1(11):1126-9. doi: 10.1038/nm1195-1126. Nat Med. 1995. PMID: 7584976 No abstract available.
-
Rational design of vaccines for AIDS and influenza.Trans Am Clin Climatol Assoc. 2012;123:9-15; discussion 15-6. Trans Am Clin Climatol Assoc. 2012. PMID: 23303965 Free PMC article.
-
[AIDS vaccine].Pneumonol Alergol Pol. 1991;59(3-4):146-52. Pneumonol Alergol Pol. 1991. PMID: 1843911 Review. Polish. No abstract available.
-
The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus.Nat Rev Microbiol. 2008 Feb;6(2):143-55. doi: 10.1038/nrmicro1819. Nat Rev Microbiol. 2008. PMID: 18197170 Review.
-
Quest for an effective AIDS vaccine takes a new tack.Lancet. 2011 Jul 16;378(9787):213-4. doi: 10.1016/s0140-6736(11)61109-4. Lancet. 2011. PMID: 21770060 No abstract available.
References
-
- Anon (2007) HIV vaccine failure prompts Merck to halt trial. Nature 44: 390 - PubMed
-
- AVERT (2010) Funding for the HIV and AIDS Epidemic. Horsham, UK: Averting HIV and AIDS http://www.avert.org/aids-funding.htm
-
- Gorse GJ, Rogers JH, Perry JE, Newman FK, Frey SE, Patel GB, Belshe RB (1995) HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva. The NIAID AIDS Vaccine Clinical Trials Network. Vaccine 13: 209–214 - PubMed
-
- HIV Vaccines and Microbicides Resource Tracking Working Group (2010) Advancing the Science in a Time of Fiscal Constraint: Funding for HIV Prevention Technologies in 2009. New York, NY, USA: Global Advocacy for HIV Prevention. www.avac.org
-
- Médecins Sans Frontières (2009) Punishing Success? Early Signs of a Retreat from Commitment to HIV/AIDS Care and Treatment. Geneva, Switzerland: Médecins Sans Frontières
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous